Tag: Moderna

February 20, 2023

A new study found that a previous COVID-19 infection offers at least the same level of protection as two doses of high-quality mRNA vaccines, such as Moderna and Pfizer-BioNTech. Additionally, people who are infected with the virus may be protected […]

October 13, 2022

Children as young as 5 years old can now receive an updated COVID-19 booster following a decision by the Food and Drug Administration to expand its authorization of reformulated shots from Moderna and partners Pfizer and BioNTech. Moderna’s vaccine, which […]

September 30, 2022

Pfizer and Moderna now both have new bivalent COVID booster shots that not only target the original strain of coronavirus, but also the highly contagious omicron subvariants that are dominant throughout the country. These booster shots are readily available at […]

August 31, 2022

The Food and Drug Administration has authorized updated COVID-19 booster vaccines for emergency use, hoping the reformulated shots from partners Pfizer and BioNTech and Moderna can curb an expected wave of new infections this winter. The FDA on Wednesday cleared […]

June 13, 2022

COVID-19 vaccines have been authorized in the U.S. for a year and a half, with the FDA progressively expanding their clearances to cover broader and broader swathes of the population. Yet they are still unavailable to the youngest children, who […]

May 17, 2022

A comparison of four COVID-19 vaccinations shows that messenger RNA (mRNA) vaccines — Pfizer-BioNTech and Moderna — perform better against the World Health Organization’s variants of concern (VOCs) than viral vector vaccines — AstraZeneca and J&J/Janssen. Although they all effectively […]

May 6, 2022

Once viewed as a convenient, one-dose alternative to the multi-shot regimens from Pfizer and Moderna, J&J’s shot has instead been marred by safety concerns that have curtailed its use in the U.S. and elsewhere. Even before the vaccine was launched […]

May 5, 2022

Both Moderna and Pfizer maintained their financial forecasts for COVID-19 vaccine sales this year, estimating product revenue that between them totals more than $50 billion. Yet the trajectory of those sales has become harder for analysts to predict amid questions […]

March 21, 2022

Last week, both Pfizer and Moderna applied for emergency use authorization (EUA) of additional booster doses — in essence, fourth doses — of their COVID-19 vaccines. The companies cite waning protection and believe fourth doses are needed. While Pfizer has […]

January 18, 2022

Israeli researchers on Monday said preliminary data show a second booster shot of the Pfizer and Moderna COVID-19 vaccines will “probably” not create enough antibodies to prevent infection from the omicron variant. Gili Regev-Yochay, an infectious disease expert at Sheba […]

December 21, 2021

Moderna reported on Dec. 20 that its currently authorized booster dose raises the level of antibodies able to neutralize the Omicron variant. The company performed preliminary tests to determine how well blood sera from people who had received its booster […]

December 3, 2021

To date, the coronavirus disease 2019 (COVID-19) has claimed more than 5.23 million lives globally. This pandemic has been caused by a novel coronavirus, namely, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which was first reported in 2019 in Wuhan, China. […]

November 29, 2021

Facing a coronavirus variant that experts fear could more easily evade vaccine protection, drugmakers raced last week to set in place plans to respond to omicron, the latest threat in the nearly two-year-old COVID-19 pandemic. BioNTech, which partnered with Pfizer […]

October 14, 2021

The COVID-19 vaccine made by Moderna is the second to get the greenlight from a panel of experts assigned to advise the Food and Drug Administration (FDA). On Thursday afternoon, a 19-member committee voted unanimously in favor of advising the […]

August 25, 2021

The debate surrounding the need for boosters has largely centered on the two messenger RNA shots from Pfizer and Moderna, each of which has been the most widely used in the U.S. and, as a result, have the most detailed […]

August 5, 2021

Moderna said its COVID-19 vaccine remained 93% effective through six months after the second shot, as it reported second-quarter earnings and revenue that beat expectations. A final analysis of the company’s late-stage study, described in a statement on Thursday, suggests […]

May 25, 2021

In a release on May 25, Moderna says its vaccine is safe and efficacious among 12- to 18-year olds. The company reported results from its combined Phase 2 and 3 study involving more than 3,700 teens who were randomly assigned […]

May 17, 2021

President Joe Biden said Monday that the U.S. will share an additional 20 million doses of COVID-19 vaccines with the world in the coming six weeks as domestic demand for shots drops and global disparities in distribution have grown more […]

April 29, 2021

As safety concerns over COVID-19 vaccines from AstraZeneca and Johnson&Johnson–Janssen have led to disruptions in the inoculation efforts of numerous countries relying on those shots, companies like Moderna are attempting to fill the resulting gaps. The Massachusetts-based biotech company announced […]

April 16, 2021

Johnson & Johnson privately asked Covid-19 vaccine rivals Pfizer and Moderna to join a study looking into the potential risk of blood clots but the companies declined, The Wall Street Journal reported Friday, citing people familiar with the matter. Executives […]